Related Experiment Video
Updated: Feb 13, 2026

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists
Fabio A Facchini1, Lenny Zaffaroni1, Alberto Minotti1
1Department of Biotechnology and Biosciences , University of Milano-Bicocca , Piazza della Scienza, 2 , 20126 Milano , Italy.
Synthetic TLR4 antagonists with specific carbon chain lengths show varying efficacy. Shorter chains (C10-C14) stabilize the MD-2/TLR4 complex and inhibit LPS signaling, unlike longer chains (C16).
Area of Science:
- Medicinal Chemistry
- Immunology
- Structural Biology
Background:
- Toll-like receptor 4 (TLR4) antagonists are crucial for modulating inflammatory responses.
- Understanding the structure-activity relationship (SAR) of synthetic TLR4 antagonists is key to developing potent therapeutics.
- Glucosamine-based compounds with varying lipophilic chains represent a promising class of TLR4 antagonists.
Purpose of the Study:
- To investigate the SAR of novel glucosamine-based synthetic TLR4 antagonists.
- To determine the impact of fatty acid chain length on the binding affinity and inhibitory activity against the MD-2/TLR4 complex.
- To explore the correlation between molecular conformation, aggregation state, and TLR4 antagonist potency.
Main Methods:
- Molecular modeling to predict the stabilization of the MD-2/TLR4 antagonist conformation.
- In vitro binding experiments using human MD-2 to assess binding affinity.
- Cell-based assays to measure inhibition of LPS-stimulated TLR4 signaling in human and murine cells.
- Spectroscopic techniques (FTIR, NMR, SAXS) to analyze aggregation states in aqueous solutions.
Main Results:
- Molecular modeling indicated higher stabilization of the MD-2/TLR4 antagonist conformation for compounds with C10, C12, and C14 chains compared to C16.
- Binding experiments revealed higher affinity for C12 and C14 variants with human MD-2; C16 showed no interaction.
- All variants, except C16, inhibited LPS-stimulated TLR4 signaling, with potency correlating to MD-2 affinity.
- Aggregation state in solution, dependent on fatty acid chain length, influenced TLR4 activity.
Conclusions:
- Fatty acid chain length is a critical determinant of TLR4 antagonist activity.
- Optimal chain lengths (C12-C14) enhance binding affinity and inhibitory potency by stabilizing the MD-2/TLR4 complex.
- The aggregation state of these synthetic antagonists in solution plays a role in their biological activity.
More Related Videos
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Related Concept Videos
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Local Anesthetics: Chemistry and Structure-Activity Relationship
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...